Abstract
Traditionally, genetic carrier screening is performed to assess fetal risk. However, Expanded Carrier Screening (ECS) identifies carriers of recessive conditions with potential for maternal phenotypic expression. Some carriers have increased risk for cancer, bleeding, and/or cardiovascular disease. We evaluated whether the identification of a genetic mutation with potential for maternal phenotypic expression prompted patients to pursue further care in our health system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
